Stock listing

OCGN Stock Price, News, Filings & Events — Ocugen, Inc.

Selected listing: OCGN · BIVA · MXN · MX

This page tracks Ocugen, Inc.'s OCGN:BIVA listing on BIVA in MXN for MX, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following OCGN:BIVA. OCGN:BIVA is the stock-level entry point for investors researching Ocugen, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Ocugen, Inc. is a public company traded under the ticker OCGN in the American market. The company has a market capitalization of approximately $409.6 million. Ocugen focuses on developing innovative biopharmaceutical products to address unmet medical needs.

OCGN:BIVAMXNMXUpdated August 21, 2026
Ocugen, Inc. logo
Ticker
OCGN:BIVA
Asset type
Stock
Market cap
$471.4M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
BIVA
Currency
MXN

Ocugen, Inc. OCGN:BIVA stock context

This page tracks Ocugen, Inc.'s OCGN:BIVA listing on BIVA in MXN for MX, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following OCGN:BIVA. OCGN:BIVA is the stock-level entry point for investors researching Ocugen, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Ocugen, Inc. is a public company traded under the ticker OCGN in the American market. The company has a market capitalization of approximately $409.6 million. Ocugen focuses on developing innovative biopharmaceutical products to address unmet medical needs.

Latest news from Ocugen, Inc.

All Ocugen, Inc. news →

Research Ocugen, Inc.

Alternate listings